Definium Therapeutics (DFTX)

NEUTRAL by u/buckwildboy | Jun 23, 2026 | 1↑ 0 comments | 31 views | VIEW ON REDDIT

$DFTX

$DFTX DEFINIUM THERAPEUTICS, INC. HEALTHCARE EQUITY SIMULATION

$42.09

+5.91 (+16.33%)

LAST PRICE · 15 MIN DELAY

DAY CHG +16.33%

5D CHG +74.21%

30D CHG +87.90%

AI SUMMARY — Definium Therapeutics (DFTX) is a clinical-stage biopharmaceutical company developing novel therapeutics with potential in multiple disease areas. Key risks include clinical trial failures, regulatory setbacks, dilution from future financing, and typical biotech execution risks.

TICKER	DFTX	USER	u/buckwildboy
RATING	NEUTRAL	ENTRY	$36.90
POSITION	271 sh SYN	BOOK VAL	$9998.55
CURRENT	$42.09	P&L %	+14.08%
CURR VAL	$11406.39	P&L $	+1407.84